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Highlights 
• We investigated the effect of inhaled carbogen on EEG recordings from five paediatric 
NCSE patients. 
• The quantified results of EEG indicate non-homogeneous effect of carbogen. 
• The non-homogeneous effects are may be due to the varied neural disabilities across 
patients. 
 
Abstract 
Objective: To quantify the effect of inhaled 5% carbon-dioxide/95% oxygen on EEG recordings from 
patients in non-convulsive status epilepticus (NCSE). 
Methods: Five children of mixed aetiology in NCSE were given high flow of inhaled carbogen (5% 
carbon dioxide/95% oxygen) using a face mask for maximum 120s.  EEG was recorded concurrently in 
all patients. The effects of inhaled carbogen on patient EEG recordings were investigated using band-
power, functional connectivity and graph theory measures. Carbogen effect was quantified by measuring 
effect size (Cohen’s d) between “before”, “during” and “after” carbogen delivery states. 
Results: Carbogen’s apparent effect on EEG band-power and network metrics across all patients for 
“before-during” and “before-after” inhalation comparisons was inconsistent across the five patients. 
Conclusion: The changes in different measures suggest a potentially non-homogeneous effect of 
carbogen on the patients’ EEG. Different aetiology and duration of the inhalation may underlie these 
non-homogeneous effects. Tuning the carbogen parameters (such as ratio between CO2 and O2, duration 
of inhalation) on a personalised basis may improve seizure suppression in future.  
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Introduction 
Status epilepticus (SE) is a situation of continuing seizure activity or repetitive seizures without 
recovery lasting (by convention) over 30 minutes (DeLorenzo et al., 1998). Morbidity and 
mortality are affected by factors including age, aetiology and time to first treatment 
(Lowenstein, Alldredge 1993, Towne et al., 1994). Non-Convulsive Status Epilepticus (NCSE) 
is a subtype of SE again of varied aetiology (Maganti et al., 2008), and is characterised by more 
subtle SE without prominent motor signs but generally reduced awareness of surroundings and 
responsiveness (Walker 2007). NCSE is often observed in the context of pre-existing 
neurological conditions such as injury and neurogenetic syndromes associated with severe 
epilepsy or learning difficulties (Galimi 2012). NCSE should be suspected in children with 
epilepsy who undergo an otherwise unexplained deterioration in behaviour, speech, memory, 
or school performance (Galimi 2012). 
Many treatments for convulsive SE have anaesthetic or sedative properties. This is 
disadvantageous in NCSE as sedation can activate NCSE and children are at increased prior 
risk of respiratory problems (Forsyth et al., 2016). The ideal treatment in this case would be 
immediate acting, non-drowsy, maintaining respiratory function and acting for a sustained 
period. Tolner et al., (2011) showed that induction of temporary mild respiratory acidosis 
(reduction of pH levels) by inhaling carbogen (5% carbon dioxide and 95% oxygen) has 
anticonvulsant action, and this would be of potential value in NCSE. Carbogen has shown to 
terminate acute onset seizures in rats, non-human primates and adult humans (Lennox et al., 
1936, Pollock et al., 1949, Pollock 1949, Dahlberg-Parrow 1951, Woodbury et al., 1955, Meyer 
JS 1961, Ziemann et al., 2008). 
During NSCE, electroencephalographic (EEG) activity is abnormal. Patient EEG dynamics can 
include pathological polyspike & slow waves, generalised slowing, and burst-suppression 
(Sutter, Kaplan 2012). The effect of carbogen on NCSE EEG is not well understood, however.  
To quantify changes in EEG dynamics, several methods are available.  Band-power analysis 
shows EEG signal power in particular frequency bands, and functional connectivity – the 
inference of brain networks by measuring signal similarity - has been used widely in epilepsy 
to show cortical network organisation before, during, and after seizures (Burianova et al., 2017, 
Tracy, Doucet 2015, Abreu et al., 2019, Beniczky et al., 2013, Sutter, Kaplan 2012, Kaplan 
2007). Graph theory metrics can further be applied to functional networks to assist 
interpretation, and elucidate specific aspects of the network. For example, clustering coefficient 
and path length are two graph theory measures commonly used to quantify local and global 
properties of a network (Bullmore, Sporns 2009). These two measures have also been shown to 
vary over the course of a seizure (Schindler et al., 2008). 
In this study we investigated the effect of carbogen on band power and functional connectivity 
across five frequency sub-bands (delta, theta, alpha, beta and gamma).  
  
2. Methods 
The methods are organized in five main sections: (1) patient information and the corresponding 
EEG recordings, (2) data pre-processing, (3) band-power analysis, (4) graph-theoretical 
measures, and (5) statistical analysis. Fig. 1 summarises the whole analysis pipeline. 
2.1 Patient information and recordings 
We retrospectively studied five NCSE patients for whom EEG data was acquired in 2016 across 
three different locations and a detailed description is provided in (Forsyth et al., 2016). Patients 
selected for this study had all been diagnosed with epilepsy with either known aetiologies or 
different underlying neurodevelopmental disabilities. The mean age of the sample is 7± 3.85 
years (mean ± standard deviation), of which four patients were male. Children in NCSE were 
given high flow inhaled carbogen by face mask for maximum 120s (113s±7s) with concurrent 
EEG measurement. All recordings were performed with a standard 10-20 clinical recording 
system (Forsyth et al., 2016). The clinical and demographic information of all patients in this 
study is summarised in Table 1. 
Patient Gender  Age 
[yrs] 
Aetiology Number of 
Electrodes 
Sampling 
rate [Hz] 
Pre-
inhalation 
EEG-
Duration 
[s] 
Post-
inhalation 
EEG-
Duration 
[s] 
1 M 4 Angelman-Syndrom 20 500 1200 1158 
2 F 10 Lissencephaly 19 256 1200 979 
3 M 3 Lissencephaly 
(PAFAH1B1 
mutation) 
20 256 416 1128 
4 M 13 Alper mitochondrial 
depletion syndrom 
(POLG1 mutation) 
20 256 989 1532 
5 M 5 Angelman 20 256 1200 1224 
Table 1 Clinical and demographic information of all patients 
Patient EEG activity was recorded continuously 1001.08 ± 303.55s pre-inhalation, during 
inhalation, and 1204.3 ± 182.45s post carbogen inhalation. A provision in the protocol allowed 
for the premature discontinuation of inhalation if the clinicians (including parents) felt it was 
any distress (Forsyth et al., 2016). The data were collected under to ethical guidelines and 
protocols were monitored by a responsible clinician.  
2.2 Data pre-processing: 
The data was notched at 50Hz (to exclude power line interference), and band-pass filtered 
between 1 to 70Hz using forward and backward 2nd order Butterworth filter. Data was visually 
inspected for amplifier saturations or noisy channels; the eye blink-artefacts were rejected using 
Independent Component Analysis (ICA). For data analysis we extracted three epochs from the 
EEG data of every patient: “before” (immediately before inhalation of carbogen), “during” 
(during inhalation of carbogen) and “after” (immediately after inhalation of carbogen). The 
length of each epoch in “before” and “after” state is 120s. The length of epoch in “during” state 
varies between 106s-120 across the patients.    
2.3 Band-power analysis: 
A two second sliding window with 50% overlap was used to extract absolute spectral power in 
five different frequency bands (delta: 1-4Hz, theta: 4-8 Hz, alpha: 8-13 Hz, beta: 13-30 Hz, and 
gamma: 30-70Hz) across each channel. The mean absolute powers (and the standard deviations) 
in each sliding window were averaged across windows for each frequency band, channel and 
patient. This gives five features per channel across three different states (before, during, and 
after) for each patient. This is visually summarised in Fig 1 (A-C). The spatial average time 
series (average over all the channels) in broadband (1-70Hz) has also been plotted in Fig 2 
across three states to visualise the effect of carbogen over time. The data was smoothed using 
a moving median filter (n = 31), to minimize the fluctuation of the signal for visualisation 
purpose, however, all the statistical calculations were carried out on original non-smoothed 
signal (Fig S1 in supplementary materials). 
 
Fig 1: Analysis Pipeline (A-F) 
(A). Pre-processed EEG signal in “before”, “during” and “after” states (B). Band-power computed across all the 
channels for every sliding window (C). Windowed band-power across all the channels used for topographic and 
spatial average time series plots. (D-E) windowed correlations matrices for every sliding window and then 
averaged over time (F). Illustrative networks demonstrating path length and clustering coefficient. (G) Pre-
processed EEG time series for two example locations for Patient 3. 
 
 
 
2.4 Network construction & graph theory analysis 
The same EEG segments (before, during, after) used in band-power analysis were also used 
here to calculate the functional connectivity (amplitude correlation) and graph theory measures. 
The data has been bandpass filtered in the above-mentioned frequency bands followed by a 
sliding window analysis, as in band-power analysis. Each window resulted in a functional 
connectivity matrix (absolute Pearson’s correlation matrix and diagonal correlation values were 
set to zero) through which graph theory measures (clustering coefficient and path length) were 
calculated using Brain Connectivity Toolbox (Rubinov, Sporns 2010). This is visually depicted 
in Fig 1 (D-F). The spatial average broadband functional connectivity, path length and 
clustering coefficient time series have been plotted in Fig 3 across three states to visualise the 
effect of carbogen across time.  
The data was smoothed using a moving median filter (n = 31), to minimize the fluctuation of 
the signal for visualisation purpose, however, all the statistical calculations were carried out on 
original non-smoothed signal which can be found in Fig S2-S4 in supplementary materials. 
2.5 Statistical analysis 
The effect size (Cohen’s d) comparing the states “before” to “during”, and “before” to “after” 
across all the channels and frequency bands was plotted in topographical plots in Fig 2. 
Additionally, we calculated the actual percentage change (equation (1)) of the band-power from 
“before” to “during” and “before” to “after” states across all the electrodes for each patient in 
each frequency band. The percent changes are summarised in Fig S5 in supplementary material.   
C = 
(BPpost – BPpre)
(BPpost + BPpre) 
       (1) 
BPpost is band-power in "during" or "after" states. 
BPpre is band-power in "before" state.   
The effect sizes were also calculated for the functional connectivity in each entry of the matrix. 
Only medium and large effect sizes (threshold >=0.5) are displayed in Fig 3. The time varying 
net broadband functional connectivity (mean of connectivity matrix across every sliding 
window) is plotted in Fig 3. 
Permutation test (10,000 permutations; mean) and Cohen’s d are used to quantify the effect of 
carbogen on patient’s EEG measures (band-power and functional connectivity).  
  
3 Results: 
The results section is divided into two sections. First, the band-power analysis and second, the 
functional network analysis. For brevity, two example patients’ results are presented in full, 
with the remaining in the supplementary material.  
3.1 Band Power Analysis: 
The effect size of the band-power across all channels in each frequency sub-band for each 
patient in the “before-during” and “before-after” comparison is summarised in Fig 2 (A, B, D, 
E, G- L). The spatial average broadband time series and effect sizes show no clear or consistent 
pattern across all patients. In the “before-during” comparison, a positive effect indicates 
decrement of absolute band-power in “during” state relative to “before” state, whilst an 
increment indicates the opposite. The above statement also applies to the “before-after” 
comparison.  
Figure 2C shows the net (spatial average) broadband time series for Patient 3. The effect sizes 
of “before-during” and “before-after” comparisons indicate small (d=0.32, p=0.03; d=-0.17, 
p=0.30) effects. The effect sizes in “before-during” comparisons (Fig 2A) indicate a small effect 
across all the frequency bands. The same is observed in the “before-after” comparison with an 
exception in the gamma band. The effect size and p-values across every channel for “before-
during” and “before-after” comparisons are summarised in Table S5 and Table S6 in 
supplementary materials. This result indicates a small effect of carbogen on the EEG band-
power of Patient 3. 
 Fig 2: Band-power analysis 
(A, D, G, I, K) Effect sizes (Cohen’s d) of the band power change of “before-during” and (B, E, H, J, L) “before-
after” across five frequency bands.  (C, F) Time series of the average band-power in broadband (1-70Hz) for 
Patient 3 and Patient 5 respectively. Positive effect size denotes decrement in absolute band power.  
 
In contrast to Patient 3, large effects are observed in “before-during” and “before-after” 
comparisons for the EEG in Patient 5 (summarised in plots in Fig 2D, E). These effect sizes 
indicate the suppression of band-power especially in the lower frequency bands during and after 
carbogen inhalation. The effect size and p-values are summarised in Table S9 and Table S10 in 
supplementary materials. The suppression of band-power is visible in the sub-bands (Fig 2 D 
and E), however, it cannot be observed in the average broadband time series in Fig 2F (“before-
during”: d=-0.14; p=0.47 and “before-after”: d=0.01; p=0.96). 
The two representative patients: Patient 3 and Patient 5 indicates contrasting effects of carbogen 
across all the sub-bands and broadband. This non-homogenous effect of the carbogen on 
absolute band-powers is also observable across three other patients (Fig 2 (G)-(L)). The net 
broadband time series (for the remaining patients; Fig S2 F-H) and normalised sub-band time 
series (for all the patients; A-E) can be found in Fig S6 in supplementary materials. 
Supplementary Tables S11-S12 and Tables S1-S10 contain the effect sizes and permutation test 
p-values for broadband time series and individual channels across all the sub-bands 
respectively.  
3.2 Network Analysis 
3.2.1 Functional connectivity 
In Patient 3 (Fig 3 A-B), the functional connectivity in the “before-during” comparison does 
not show any medium or large effects (d >=0.5) of the carbogen in the delta, theta or alpha sub-
bands. Beta and gamma bands show reduction of the connectivity between few nodes. In the 
“before-after” (Fig 3B) comparison, carbogen shows only a small effect in the gamma band. 
The insignificance (d=0.03, p=0.82) of carbogen inhalation in “during” state, and significant 
effect on post inhalation (d=0.31, p=0.03) can also be seen in Fig 3C across the broadband time 
series. 
Patient 5 on the other hand, shows a clear suppression in the net broadband functional 
connectivity when comparing “during” to “after” states (Fig 3H).  This indicates a significant 
effect during carbogen inhalation (d=0.82, p<0.001) and a small but significant effect in the 
“after” inhalation state (d=0.42; p<0.001). The topographical plots in patient 5 (Fig 3(F)-(G)) 
also show contrasting results in comparison to Patient 3. In Fig 3(F), the functional connectivity 
is suppressed in lower frequencies during carbogen inhalation, however, alpha and beta bands 
are less affected and also show some increment in connectivity. In the higher frequencies 
(gamma), the predominant effect of elevation in the connectivity between most nodes can be 
observed in the “before-during” comparison. The same observations can be made in the 
“before-after” comparison (Fig 3(G)).  
The results of functional connectivity analysis of the other three patients also suggests this non-
homogenous influence of carbogen on the EEG. The sub-band functional connectivity (Fig S7 
A-E) and broadband time series (Fig S7 F-H) results for the remaining subjects are summarised 
in supplementary materials. The effect size and permutation test p-values for the remaining 
subjects can be found in Table S11 and Table S12 respectively in supplementary materials.  
3.2.2 Graph theory 
The path length and average clustering coefficient in broadband for two representative patients 
is plotted as a time series in Fig 3 (D, E, I, J). In Patient 3, a significant (d=-0.36, p=0.01) effect 
is observed in the “after” states (Fig 3D) in path length only. The net clustering coefficient also 
exhibits the similar property as path length.  
 Fig 3: Functional connectivity and graph-theory analysis 
(A, F, K, M, O) Effect sizes (Cohen’s d) of the functional connectivity change of “before-during” and (B, G, L, N, 
P) “before-after” for five Patients. (C, H) Time series of net (average) correlation coefficient in broadband (1-
70Hz) for Patient 3 and Patient 5. (D, I) Time series of the net (average) path length in broadband (1-70Hz) for 
Patient 3 and Patient 5. (E, J) Time series of the net (average) clustering coefficient in broadband (1-70Hz) for 
Patient 3 and Patient 5. Positive effect size denotes decrement in functional connectivity. 
In contrast to Patient 3, in Patient 5 (Fig 3I), the net path length has increased significantly in 
“during” (d=-0.88, p=0.00) and “after” states (d=-0.41, p=0.004; Fig. 3I). However, clustering 
coefficient has been significantly supressed “during” (d=0.81, p=0.00) and “after” (d=0.39, 
p=0.007) inhalation of carbogen (Fig 3J). The results for the remaining subjects also show 
inconsistency in the effect of carbogen amongst them. The sub-band (Fig S8 A-E) and 
broadband path length time series (Fig S8 F-H) for the remaining subjects are summarised in 
supplementary materials. The sub-band (Fig S9 A-E) and broadband clustering coefficient time 
series (Fig S9 F-H) results for the remaining subjects are summarised in supplementary 
materials. 
Discussion 
The present work investigates the relationship between carbogen inhalation and quantitative 
EEG measures. Specifically, we compared spectral power, functional connectivity and graph 
theory measures “before” to “during” and “after” the inhalation of carbogen in paediatric 
NCSE. For these methods we did not find evidence to suggest a common effect of carbogen on 
NCSE EEG. 
Lennox (Lennox et al., 1936) applied 10% CO2 to successfully supress the spike wave EEG 
activity. This was extended in several studies on rodent, canine and non-human primate models 
(Pollock et al., 1949, Pollock 1949, Dahlberg-Parrow 1951, Mitchell, Grubbs 1956, Balestrino, 
Somjen 1988, Ziemann et al., 2008). 15-30% CO2 prevented electrically induced convulsions 
in psychiatric patients (Pollock et al., 1949). Tolner et al (Tolner et al., 2011) in their pilot study 
on seven patients with drug resistant epilepsy used standard medical carbogen (5% CO2) and 
reported the rapid termination of electrographic seizures despite the fact that the application of 
carbogen was started after the seizure generalization. In the above study, none of the patients 
had any underlying neural disability except “epilepsy”. This is important to note because the 
cohort in our study has mixed aetiology.  
The inhalation of carbogen induces a mild temporary acidosis (i.e. lowering pH) and when 
reduced to a critical value (blood pH-level<7.35) this is termed as acidaemia (Hamilton et al., 
2017). Acidosis attenuates excitatory neurotransmission by reducing NMDA-receptor activity 
(Brodie, Sills 2011) whilst enhancing inhibitory neurotransmission by facilitating the 
responsiveness of GABAA receptors (Brodie, Sills 2011). Possible cellular mechanisms 
(Chesler 2003) involve direct effects of pH on voltage and ligand-gated ion channel 
conductance (Traynelis et al., 1995, Pasternack et al., 1996, Ziemann et al., 2008) and adenosine 
signalling (Dulla et al., 2009). Therefore, one may expect a decrease in the EEG band-power, 
which was also reported previously (Bloch-Salisbury et al., 2000). However, we found an 
increase in band-power during carbogen delivery in Patient 5 (Fig 2F). 
In Patient 3, no substantial effects were observed in “during” and “after” states relative to the 
“before” state. However, in Patient 5, carbogen delivery was associated with reduce correlation 
between the nodes (i.e. positive effect size) in lower frequency bands. This may be due to the 
fact that acidosis introduced by the carbogen might not be sufficient enough to supress the high 
frequency activity. A small, and insignificant change of path length and clustering coefficient 
in during state, can be observed in Patient 3. This might be due to the fact that carbogen was 
inhaled not at the seizure onset but very late into the seizure causing a delayed acidosis effect. 
This delayed effect might not be enough to terminate the seizure state and show change in EEG 
recordings. Application of carbogen immediately after the seizure onset might have strong 
anticonvulsant and therapeutic interventions (Tolner et al., 2011). 
Overall the effect of the carbogen on patient EEG was inconsistent across all measurements 
used. Note that although in our analysis no measure showed a consistent effect, this does not 
prohibit the possibility of the existence of a measure showing consistent effects across patients. 
In other words, absence of evidence does not necessarily represent evidence of absence and our 
finding should therefore be considered with this in mind. Our choices of measures are routine 
in the field of quantitative EEG analysis and have been shown to demonstrate differences in a 
wide range of settings (Douw et al., 2010b, Douw et al., 2010a, Bullmore, Sporns 2009, Guo et 
al., 2010, Lee et al., 2017). Other factors for the ineffectiveness of carbogen might be, first, the 
lack of “aggressiveness” (concentration/duration) and second, the heterogeneity of the 
underlying aetiology of the patients.  
Even though carbogen has the potential to terminate NCSE seizures in humans, our results 
suggest different effects in different subjects.  This heterogeneity may be related to underlying 
aetiology, which should be considered in future studies.  
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